Peer-reviewed Publications (Original research)

Peer-reviewed Publications (Original research)

• Inoue K, Figueroa F, Kondo N, Tsugawa Y (2022). Changes in Industry Marketing Payments to Physicians during the COVID-19 pandemic: Quasi-experimental Difference-in-difference Study. BMJ Medicine; 1(1)
• Suzuki N, Inoue K (co-first), Noh JY, et al (2022). The Mediation Role of TRAb in the Relationship between Age and Severity of Hyperthyroidism in Graves’ Disease. Thyroid 32(10):1243-1248
• Inoue K, Watson KE, Kondo N, Horwich T, Hsu W, Bui A, Duru OK. (2022). Association of Intensive Blood Pressure Control and Living Arrangement on Cardiovascular Outcomes by Race. JAMA Network Open; 1;5(3):e222037
• Inoue K, Ritz B, Arah OA. (2022). Causal Effect of Chronic Pain on Mortality through Opioid prescriptions: An Application of the Front-Door Formula. Epidemiology;33(4):572-580
• Inoue K, Goto A, Kondo N, Shinozaki T. (2022). Bias amplification in the g-computation algorithm for time-varying treatments: a case study of industry payments and prescription of opioid products. BMC Medical Research Methodology; 22(1):120.
• Inoue K, Horikoshi H, Omura M, Tsurutani Y, Saito J, Nishikawa T (2022). Association between aldosterone and hypertension among patients with overt and subclinical hypercortisolism. Journal of Endocrine Society 7(1):bvac167
• Goto R, Nianogo R, Okubo Y, Inoue K. (2022). Evaluation of Obesity Trends Among US Adolescents by Socioeconomic Status, 1999-2018. JAMA Pediatrics: 176(9), 937-940.
• Sawada R, Kondo N, Inoue K. (2022). Association between Income and Healthcare Utilization among US Adults at High Risk of CVD, 1999-2018. Endocrine Practice: 28(9), 921-922.
• Yazawa A, Shiba K, Inoue Y, Okuzono S, Inoue K, Kondo N, Kondo K, Kawachi I. (2022). Early childhood adversity and late-life depressive symptoms: unpacking mediation and interaction by adult socioeconomic status. Social Psychiatry and Psychiatric Epidemiology: 57(6), 1147-1156.
• Kanehara R, Goto A, Watanabe T, Inoue K, Taguri M, Kobayashi S, Imai K, Saito E, Katanoda K, Iwasaki M, Ohashi K, Noda M, Higashi T. (2022) Association Between Diabetes and Adjuvant Chemotherapy Implementation in Patients with Stage III Colorectal Cancer. J Diabetes Investig. doi: 10.1111/jdi.13837
• Yagome S, Sugiyama T, Inoue K, Igarashi A, Bouchi R, Ohsugi M, Ueki K, Goto A. (2022) Influence of the COVID-19 pandemic on overall physician visits and telemedicine use among patients with type 1 or type 2 diabetes in Japan. Journal of Epidemiology: JE20220032
• Ueda T, Tsurutani Y, Osada J, Inoue K, Hoshino Y, Ono M, Nakai K, Saito J, Yumoto K, Nishikawa T. (2022) Comparison of Echocardiographic Changes Between Surgery and Medication Treatment in Patients with Primary Aldosteronism. Journal of American Heart Associasion: 11(13):e023813.
• Tsai K, Inoue K, Mcclean M, Kaunitz JD, Akiba Y, Lee ML, Neverova NV, Currier JW, Ebrahimi R, Bashir MT, Leung AM. (2022) Iodine Contrast Exposure and Incident COVID-19 Infection. Frontiers in Medicine 9:1033601
• Kubo H, Tsurutani Y, Inoue K, Watanabe K, Yamazaki Y, Sunouchi T, Hoshino Y, Hirose R, Katsuragawa S, Tannai H, Shibahara Y, Kakuta Y, Matsui S, Saito J, Omura M, Sasano H, Nishikawa T. (2022) Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression. PLoS One;17(4):e0267732.
• Yoshihara A, Yoshimura Noh J, Inoue K, et al (19 authors). (2022) Prediction model of Graves' disease in general clinical practice based on complete blood count and biochemistry profile. Endocr J. doi: 10.1507/endocrj.EJ21-0741.
• Inoue K, Horwich T, Bhatnagar R, Bhatt K, Goldwater D, Seeman T, Watson KE. (2021). Urinary stress hormones, hypertension, and cardiovascular events: the Multi-Ethnic Study of Atherosclerosis. Hypertension: 78(5), 1640-1647.
• Inoue K, Tsugawa Y, Mangione CM, Duru OK. (2021). Association Between Industry Payments and Prescriptions of Long-acting Insulin: An Observational Study with Propensity-Score Matching. PLOS Medicine: 18(6), e1003645.
• Inoue K, Figueroa JF, DeJong CD, Tsugawa Y, Orav EJ, Shen C, Kazi DS. (2021). Association Between Industry Marketing Payments and Prescriptions for PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors in the United States.Circulation: Cardiovascular Quality and Outcomes: 14(5), e007521.
• Inoue K, Mayeda ER, Nianogo R, Paul K, Yu Y, Haan M, Ritz B. (2021). Estimating the joint effect of diabetes and subsequent depressive symptoms on mortality among older Mexican Americans. Annals of Epidemiology: 64, 120-126.
• Inoue K, Hsu W, Arah OA, Prosper A, Aberle D, Bui A. (2021). Generalizability and transportability of the results from randomized controlled trials: An example using the National Lung Screening Trial. Cancer Epidemiology, Biomarkers & Prevention: 30(12), 2227-2234.
• Prosper A, Inoue K (co-first), Kathleen B, Bui A, Aberle D, Hsu W. (2021). Association of Inclusion of More Black Individuals in Lung Cancer Screening With Reduced Mortality. JAMA Network Open: 4(8), e2119629-e2119629
• Inoue K, Kitamoto T, Tsurutani Y, Saito J, Omura M, Nishikawa T. (2021). Cortisol Co-Secretion and Clinical Usefulness of ACTH Stimulation Test in Primary Aldosteronism: A Systematic Review and Biases in Epidemiological Studies.Frontiers in Endocrinology; 12:645488.
• Inoue K, Semba E, Yamakawa T, Terauchi Y. (2021). Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population.BMJ Open Diabetes Research & Care: 9(1), e002047.
• Inoue K, Noh JY, Yoshihara A, Watanabe N, Matsumoto M, Fukushita M, Suzuki N, Hoshiyama A, Mitsumatsu T, Suzuki A, Kinoshita A, Mikura K, Yoshimura R, Sugino K, Ito K. (2021). Delayed follow-up visits and Thyroid-Stimulating Hormone among patients with levothyroxine during the COVID-19 pandemic.Journal of Endocrine Society 6(1):bvab181
• Kato H, Ito N, Makita N, Nangaku M, Leung AM, Inoue K. (2021). Association of Serum Parathyroid Hormone Levels with All-cause and Cause-specific Mortality Among US Adults. Endocrine Practice 28(1):70-76
• Katsuragawa S, Goto A, Tsurutani Y, Fukuma S, Inoue K. (2021). No Healthcare Utilization and Death. Journal of General Internal Medicine: 1-10
• Yagi R , Inoue K. (2021). Trends in Brand-name Statin Prescriptions Among Physicians Prescribing PCSK9 inhibitors in 2016-2018. Endocrine Practice: S1530-891X.
• Lin Y, Fu M, Ding R, Inoue K, Jeon CY, Hsu W, Aberle DR, Prosper A. (2021). Patient Adherence to Lung-RADS Recommended Screening Intervals in the United States: A Systematic Review and Meta-Analysis. Journal of Thoracic Oncology 17(1):38-55
• Nakai K, Tsurutani Y, Inoue K, Matsui S, Makita K, Yamazaki Y, Sasano H, Makita N, Nangaku M, Saito J, Omura M, Nishikawa T. (2021). Steroidogenic Activity in Unresected Adrenals Associated with Surgical Outcomes in Primary Aldosteronism.Hypertension: 77(5), 1638-1646.
• Yazawa A, Shiba K, Inoue Y, Okuzono S, Inoue K, Kondo N, Kondo K, Kawachi I. (2021). Early childhood adversity and late-life depressive symptoms: unpacking mediation and interaction by adult socioeconomic status. Social Psychiatry and Psychiatric Epidemiology 57(6):1147-1156.